Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan.
Cancer Sci. 2013 Jun;104(6):773-8. doi: 10.1111/cas.12142.
The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized an international session as part of the official program of the 71st Annual Meeting of the Japanese Cancer Association to discuss the topic "Healthcare Economics: The Significance of the UN Summit non-communicable diseases (NCDs) Political Declaration in Asia." The presenters and participants discussed the growing cost of cancer in the Asian region and the challenges that are faced by the countries of Asia, all of which face budgetary and other systemic constraints in tackling and controlling cancer in the region. The session benefited from the participation of various stakeholders, including cancer researchers and representatives of the pharmaceutical industry. They discussed the significance of the UN Political Declaration on the prevention and control of NCDs (2011) as a means of boosting awareness of cancer in the Asian region and also addressed the ways in which stakeholders can cooperate to improve cancer control and treatment. Other issues that were covered included challenges relating to pharmaceutical trials in Asia and how to link knowledge and research outcomes. The session concluded with the recognition that with the onset of a super-aged society in most countries in Asia and an increasing focus on quality of life rather than quantity of life, it is more important than ever for all stakeholders to continue to share information and promote policy dialogue on cancer control and treatment.
日本国际癌症控制联盟（UICC）全国委员会和 UICC-Asia 区域办事处（ARO）组织了一次国际会议，作为日本癌症协会第 71 届年会正式会议的一部分，讨论了“医疗保健经济学：联合国非传染性疾病（NCD）峰会政治宣言在亚洲的意义”这一主题。演讲者和与会者讨论了亚洲地区癌症成本不断上升的问题，以及亚洲各国在应对和控制该地区癌症方面所面临的挑战，这些国家都面临着预算和其他系统方面的限制。该会议受益于各种利益攸关方的参与，包括癌症研究人员和制药业代表。他们讨论了《联合国预防和控制非传染性疾病政治宣言》（2011 年）的意义，认为这是提高亚洲地区对癌症认识的一种手段，并探讨了利益攸关方如何合作改善癌症控制和治疗。涵盖的其他问题包括亚洲制药试验面临的挑战，以及如何将知识和研究成果联系起来。会议最后认识到，随着亚洲大多数国家进入超级老龄化社会，以及对生活质量的重视超过了对寿命的重视，所有利益攸关方继续分享癌症控制和治疗信息并促进政策对话比以往任何时候都更加重要。
